Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
Lyell Immunopharma, a late-stage clinical company developing next-generation CAR T-cell therapies for cancer, will participate in the Baird 2026 Global Healthcare Conference. Senior management will discuss the company's clinical progress and manufacturing capabilities via a webcast. The company emphasizes its proprietary manufacturing center's capa…